[Form 4] Option Care Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Option Care Health, Inc. (OPCH) Chief Accounting Officer Nicole Maggio reported an acquisition of common stock via a restricted stock unit award. The Form 4 records a transaction dated 08/06/2025 for 7,167 restricted stock units granted at a reported price of $0, bringing her reported beneficial ownership to 26,476 shares.

The filing identifies the transaction as an acquisition (code "A") and direct ownership. The restricted stock units are disclosed to vest in full on 08/06/2027. No derivative securities or disposals are listed in Table II of the form, and the filing contains an explanatory note that the award vests in full on the stated date.

Positive

• 7,167 restricted stock units granted to Nicole Maggio are explicitly disclosed
• Beneficial ownership increased to 26,476 shares following the reported acquisition
• Vesting schedule disclosed: restricted stock units vest in full on 08/06/2027

Negative

• None.

Insights

Securities Analyst

TL;DR Routine equity grant to a senior finance officer; limited standalone investor impact based on the reported size and standard vesting.

The Form 4 shows a direct acquisition of 7,167 restricted stock units by Nicole Maggio on 08/06/2025, increasing beneficial ownership to 26,476 shares. The award carries a reported price of $0 and vests in full on 08/06/2027. Table II reports no derivative transactions. As presented, the transaction is a standard compensation grant and does not, by itself, indicate material financing or liquidity effects for the issuer.

Corporate Governance Expert

TL;DR A standard executive equity award with multi-year vesting; governance implications are routine and disclosure is straightforward.

The filing names Nicole Maggio as Chief Accounting Officer and reports an acquisition coded "A" of 7,167 restricted stock units that vest in full on 08/06/2027. The Form 4 lists direct beneficial ownership of 26,476 shares after the grant and contains an explicit vesting explanation. The disclosure format and detail are consistent with routine insider reporting obligations.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maggio Nicole

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN IL 60015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/06/2025		A		7,167(1)	A	$0	26,476	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The restricted stock units granted in this award vest in full on August 6, 2027.

	/s/ Collin Smyser, attorney-in-fact for Ms. Maggio	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Nicole Maggio report on Form 4 for OPCH?

She reported an acquisition of 7,167 restricted stock units on 08/06/2025, recorded at a price of $0.

How many shares does Nicole Maggio beneficially own after the reported transaction (OPCH)?

The Form 4 shows she beneficially owns 26,476 shares following the reported acquisition.

When do the restricted stock units granted to Nicole Maggio vest?

The restricted stock units are disclosed to vest in full on 08/06/2027.

Was the transaction reported as direct or indirect ownership on the OPCH Form 4?

The filing reports the acquisition as direct ownership and uses transaction code A (acquisition).

Did the Form 4 for OPCH report any derivative securities or disposals for Nicole Maggio?

No. Table II reports no derivative securities, and there are no disposals recorded in the filing.